111 related articles for article (PubMed ID: 10694228)
1. Enhanced nociception by exogenous and endogenous substance P given into the spinal cord in mice lacking NR(2)A/epsilon(1), an NMDA receptor subunit.
Inoue M; Mishina M; Ueda H
Br J Pharmacol; 2000 Jan; 129(2):239-41. PubMed ID: 10694228
[TBL] [Abstract][Full Text] [Related]
2. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
[TBL] [Abstract][Full Text] [Related]
4. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor activation modulates evoked release of substance P from rat spinal cord.
Malcangio M; Fernandes K; Tomlinson DR
Br J Pharmacol; 1998 Dec; 125(8):1625-6. PubMed ID: 9886751
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the nociception produced by peripheral protein kinase c activation in mice.
Ferreira J; Trichês KM; Medeiros R; Calixto JB
Pain; 2005 Sep; 117(1-2):171-81. PubMed ID: 16099101
[TBL] [Abstract][Full Text] [Related]
7. Redox modulation at the peripheral site alters nociceptive transmission in vivo.
Meotti FC; Coelho IS; Franco JL; Dafre AL; Rocha JB; Santos AR
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):272-7. PubMed ID: 18986332
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of the adenosine A(2A) receptor in mice reduces the changes in spinal cord NMDA receptor binding and glucose uptake caused by a nociceptive stimulus.
Hussey MJ; Clarke GD; Ledent C; Kitchen I; Hourani SM
Neurosci Lett; 2010 Aug; 479(3):297-301. PubMed ID: 20570711
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of intra-hippocampal CA1 and dentate gyrus injection of MK801 and AP5 in the formalin test in adult male rats.
Soleimannejad E; Naghdi N; Semnanian S; Fathollahi Y; Kazemnejad A
Eur J Pharmacol; 2007 May; 562(1-2):39-46. PubMed ID: 17362915
[TBL] [Abstract][Full Text] [Related]
10. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
11. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
[TBL] [Abstract][Full Text] [Related]
12. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
[TBL] [Abstract][Full Text] [Related]
13. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse.
Choi SS; Han EJ; Lee TH; Lee JK; Han KJ; Lee HK; Suh HW
Planta Med; 2002 Sep; 68(9):794-8. PubMed ID: 12357389
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of glutamatergic and GABAergic systems and protein kinase A pathway in the antinociceptive effect caused by p-methoxy-diphenyl diselenide in mice.
Pinto LG; Jesse CR; Nogueira CW; Savegnago L
Pharmacol Biochem Behav; 2008 Feb; 88(4):487-96. PubMed ID: 18023853
[TBL] [Abstract][Full Text] [Related]
16. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
[TBL] [Abstract][Full Text] [Related]
17. Peripheral NMDA receptor modulation of jaw muscle electromyographic activity induced by capsaicin injection into the temporomandibular joint of rats.
Lam DK; Sessle BJ; Cairns BE; Hu JW
Brain Res; 2005 Jun; 1046(1-2):68-76. PubMed ID: 15927551
[TBL] [Abstract][Full Text] [Related]
18. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
20. NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings.
Matsumoto M; Inoue M; Ueda H
Neurosci Lett; 2006 Apr; 397(3):249-53. PubMed ID: 16406342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
